{
  "id": "enwiki-001366865478",
  "slug": "2cb7",
  "title": "2CB7",
  "qid": "",
  "lead": "2CB7, also known as 2C-B-5-hemiFLY-β7, is a serotonin receptor modulator of the phenethylamine, 2C, and benzofuran families related to 2C-B. It is a cyclized phenethylamine or conformationally restrained derivative of 2C-B in which the 5-methoxy group has been cyclized into a dihydrofuran ring and the β position has been connected with the dihydrofuran ring via a propyl group to form a cycloheptane ring to form a tricyclic structure. The compound has syn and anti stereoisomers, with these isomers also being racemic mixtures of (+)- and (–)- enantiomers. The isomers of 2CB7 show affinity for the serotonin 5-HT 2A receptor, with values (K i ) of 74 to 170 nM for syn-2CB7 and 170 to 200 nM for anti-2CB7. These affinities were dramatically lower than those of 2C-B (K i = 0.66–0.88 nM). 2CB7 was first described in the scientific literature by Michael Robert Braden and David E. Nichols and colleagues in 2006. It was developed as part of scientific research into serotonin 5-HT 2A receptor ligand interactions.",
  "body": "2CB7, also known as 2C-B-5-hemiFLY-β7, is a serotonin receptor modulator of the phenethylamine, 2C, and benzofuran families related to 2C-B. It is a cyclized phenethylamine or conformationally restrained derivative of 2C-B in which the 5-methoxy group has been cyclized into a dihydrofuran ring and the β position has been connected with the dihydrofuran ring via a propyl group to form a cycloheptane ring to form a tricyclic structure. The compound has syn and anti stereoisomers, with these isomers also being racemic mixtures of (+)- and (–)- enantiomers. The isomers of 2CB7 show affinity for the serotonin 5-HT 2A receptor, with values (K i ) of 74 to 170 nM for syn-2CB7 and 170 to 200 nM for anti-2CB7. These affinities were dramatically lower than those of 2C-B (K i = 0.66–0.88 nM). 2CB7 was first described in the scientific literature by Michael Robert Braden and David E. Nichols and colleagues in 2006. It was developed as part of scientific research into serotonin 5-HT 2A receptor ligand interactions.",
  "categories": [
    "106462793",
    "106462794",
    "114646357",
    "23603337",
    "26220375",
    "27236659",
    "37750075",
    "50769796",
    "51480462",
    "54374437",
    "63007578",
    "63697623",
    "65121943",
    "67813940",
    "67819207",
    "72283819",
    "90894244"
  ],
  "license": "CC BY-SA 4.0",
  "source_uri": "https://en.wikipedia.org/w/index.php?oldid=1366865478",
  "content_hash": "",
  "created_at": null,
  "updated_at": 1785425807.0,
  "claims": [],
  "contradictions": [],
  "confidence": 0.6,
  "csl": {
    "id": "enwiki-001366865478",
    "type": "webpage",
    "title": "2CB7",
    "author": [
      {
        "family": "Anticloud FZ LLE",
        "literal": "Anticloud FZ LLE"
      }
    ],
    "container-title": "encyclopegia.org",
    "publisher": "Anticloud FZ LLE",
    "publisher-place": "Dubai, United Arab Emirates",
    "URL": "https://encyclopegia.org/a/2cb7",
    "issued": {
      "date-parts": [
        [
          2026,
          11,
          20
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          2026,
          11,
          20
        ]
      ]
    },
    "license": "CC BY-SA 4.0",
    "DOI": "eo1:enwiki-001366865478",
    "isBasedOn": "https://en.wikipedia.org/w/index.php?oldid=1366865478",
    "note": "Immutable snapshot enwiki-001366865478"
  }
}